Острый и хронический тонзиллит у детей: тактика лечения
Острый и хронический тонзиллит у детей: тактика лечения
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Интервью с доктором медицинских наук, профессором кафедры болезней уха, горла и носа ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Юрием Львовичем Солдатским.
Список литературы
1. Van Asselt GJ, Mouton RP, van Boven CP. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis. Eur J Clin Microbiol Infect 1996; 15 (2): 107–15.
2. Богомильский М.Р. Антибактериальная терапия при остром тонзиллофарингите у детей. Cons. Med. Педиатрия (Прил.). 2005; 7 (1): 5–7.
3. Greco R, De Martino L, Donnarumma G et al. Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 1995: 46 (7): 551–60.
4. Al-Mazrou K, Al-Khattaf A. Adherent biofilms in adenotonsillar diseases in children. Arch Otolaryngol Head Neck Surg 2008; 134 (1): 20–3.
5. Bearden DT, Rodvold KA. Practical pharmacology-penetration of macrolides into pulmonary sites of infection. Infect Med 1999; 16: 480–4.
6. Kaplan EL, Gooch WM, Notario GF, Craft JC. Macrolide therapy of group A streptococcal pharyngitis: ten days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than five days (azithromycin). Clin Infect Dis 2001; 32 (12): 1798–802.
7. McCarty J, Hedrick JA, Gooch WM. Clarithromycin suspension vs. penicillin V suspension in children with streptococcal pharyngitis. Adv Ther 2000; 17 (1): 14–26.
8. Quinn J, Ruoff GE, Ziter PS. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study. Clin Ther 2003; 25 (2): 422–43.
9. Takker U, Dzyublyk O, Busman T, Notario G. Comparison of five days of extended-release clarithromycin versus ten days of penicillin v for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study. Curr Med Res Opin 2003; 19 (5): 421–9.
10. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
2. Богомильский М.Р. Антибактериальная терапия при остром тонзиллофарингите у детей. Cons. Med. Педиатрия (Прил.). 2005; 7 (1): 5–7.
3. Greco R, De Martino L, Donnarumma G et al. Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 1995: 46 (7): 551–60.
4. Al-Mazrou K, Al-Khattaf A. Adherent biofilms in adenotonsillar diseases in children. Arch Otolaryngol Head Neck Surg 2008; 134 (1): 20–3.
5. Bearden DT, Rodvold KA. Practical pharmacology-penetration of macrolides into pulmonary sites of infection. Infect Med 1999; 16: 480–4.
6. Kaplan EL, Gooch WM, Notario GF, Craft JC. Macrolide therapy of group A streptococcal pharyngitis: ten days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than five days (azithromycin). Clin Infect Dis 2001; 32 (12): 1798–802.
7. McCarty J, Hedrick JA, Gooch WM. Clarithromycin suspension vs. penicillin V suspension in children with streptococcal pharyngitis. Adv Ther 2000; 17 (1): 14–26.
8. Quinn J, Ruoff GE, Ziter PS. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study. Clin Ther 2003; 25 (2): 422–43.
9. Takker U, Dzyublyk O, Busman T, Notario G. Comparison of five days of extended-release clarithromycin versus ten days of penicillin v for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study. Curr Med Res Opin 2003; 19 (5): 421–9.
10. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
Авторы
Ю.Л.Солдатский
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.